Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREVAIL VII: Persistence of Ebola Virus in Ocular Tissues and Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease

NCT03309020 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT03309020
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03309020 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREVAIL VII: Persistence of Ebola Virus in Ocular Tissues and Outcomes of Cataract Surgery in Survivors of Ebola Virus Disease
Lead sponsor
National Eye Institute (NEI)
Phase
Not applicable
Overall status
Completed
Start date
September 21, 2017
Completion date
August 1, 2019
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract